Skip to main content
Premium Trial:

Request an Annual Quote

Jorge Garces

Epigenomics has appointed Jorge Garces as president and CSO, effective Dec. 1. He will join the firm's executive board and oversee operations, R&D, clinical affairs, regulatory and quality. Prior to joining Epigenomics, Garces was CEO and president of AltheaDx. Before that, he held the same positions at Enigma Diagnostics. He also has held management positions at Hologic and GenMark Diagnostics, as well as Third Wave Technologies. 

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.